Development of a multiplex assay to detect TERC and TERT mutations associated with immunosuppression therapy failure in Aplastic Anaemia patients
Corresponding Author
Karen Shires
Division of Haematology, Department of Pathology, University of Cape Town, Cape Town, South Africa
National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa
Correspondence
Karen Shires, Division of Haematology, UCT Medical School, Cape Town, South Africa.
Email: [email protected]
Search for more papers by this authorKhethelo Xulu
Division of Haematology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Search for more papers by this authorAdri Rust
Division of Haematology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Search for more papers by this authorCorresponding Author
Karen Shires
Division of Haematology, Department of Pathology, University of Cape Town, Cape Town, South Africa
National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa
Correspondence
Karen Shires, Division of Haematology, UCT Medical School, Cape Town, South Africa.
Email: [email protected]
Search for more papers by this authorKhethelo Xulu
Division of Haematology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Search for more papers by this authorAdri Rust
Division of Haematology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Search for more papers by this author
References
- 1Young NS, Abkowitz J, Luzzatto L. New insights into the pathophysiology of acquired cytopenias. Hematology Am Soc Hematol Educ Program. 2000; 2000: 18-38.
10.1182/asheducation-2000.1.18 Google Scholar
- 2Young N, Calado R, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006; 108: 2509-2519.
- 3Passweg JR, Marsh JC. Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Hematology. Am Soc Hematol Educ Program. 2010; 2010: 36-42.
- 4Cong Y, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002; 66: 407-425.
- 5Calado R, Young N. Telomere maintenance and human bone marrow failure. Blood. 2008; 111: 4446-4455.
- 6Yamaguchi H, Baerlocher GM, Lansdorp PM, et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anaemia and Myelodysplastic syndrome. Blood. 2003; 102: 916-918.
- 7Du H, Mason P, Bessler M, Wilson D. TINF2 Mutations in children with severe Aplastic Anemia. Pediatr Blood Cancer. 2009; 52: 687.
- 8Vulliamy T, Marrone A, Dokal L, Mason PJ. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002; 359: 2168-2170.
- 9Ziegler P, Schrezenmeier H, Akkad J, et al. Telomere elongation and clinical response to androgene treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Ann Hematol. 2012; 97: 1115-1120.
- 10Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003; 362: 1628-1630.
- 11Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase in aplastic anaemia. N Engl J Med. 2005; 352: 1413-1424.
